Member News

York named CSO; Cortez takes over biochem dept; Rye receives research award

ASBMB Today Staff
Jan. 18, 2021

York named Impossible Foods CSO

John York, previously chair of the Vanderbilt University department of biochemistry, recently left that role to become the chief science officer at Impossible Foods.

John York

The startup, founded by biochemist Pat Brown and based in Oakland, California, develops and markets plant-based imitation meat. The company has put considerable effort into biochemical research to recreate the experience of eating meat, notably incorporating a heme protein from soy. The company is outspoken about its mission to combat climate change and other environmental problems by reducing meat consumption. 

“The opportunity to use biochemistry to save the planet is a spectacular motivation,” York stated in a press release from Impossible Foods.

York came to Vanderbilt from Duke University, where he was a professor for 16 years and a Howard Hughes Medical Institute investigator. In eight years at Vanderbilt, he pursued a long-standing interest in inositol phosphate signaling. He also developed a line of research into the effect of reductive sulfur fixation on iron homeostasis and physiology after the lab identified a family of proteins including both inositol phosphatases and sulfur-assimilation enzymes. According to a press statement from Vanderbilt, York deepened the university’s focus on basic science and helped make the biochemistry department the most funded by the National Institutes of Health in 2019.

Cortez takes over Vanderbilt biochemistry department

David Cortez, Richard Armstrong Professor for Innovation in Biochemistry at Vanderbilt University is serving as the interim chair of Vanderbilt’s department of biochemistry, effective Jan. 1.

David Cortez

“The people in this department and at Vanderbilt make it special, and I will do everything I can to support them as they pursue their goals,” Cortez stated in a Vanderbilt press release. 

Cortez received his Ph.D. from Duke University in molecular cancer biology and conducted postdoctoral research at the Baylor College of Medicine, and joined Vanderbilt as a young professor in 2002. His lab has studied replication stress, DNA damage responses and other pathways that control genome stability, and works on developing cancer therapeutics that target DNA damage pathways. 

Cortez is also associate director for basic sciences research at the Vanderbilt-Ingram Cancer Center. He has received awards from the National Cancer Institute, the MD Anderson Cancer Center and the Pew Charitable Trust. In 2017, he became a fellow of the American Association for the Advancement of Science.

Rye receives UNSW Medicine research award

Kerry-Anne Rye, a professor at the University of New South Wales in Sydney, Australia, and a co-editor-in-chief of the Journal of Lipid Research, has received the University of New South Wales Faculty of Medicine Award for Academic Research Excellence.

Kerry-Anne Rye

Rye, who received her Ph.D. from Flinders University in South Australia and was a postdoc at the University of Illinois at Urbana-Champaign, has been a research professor at UNSW since 2013. She is deputy head of the School of Medical Sciences, where she studies the mechanisms by which diabetes can lead to heart disease. She was the first to report that the atheroprotective high-density lipoproteins in human plasma inhibit inflammation in coronary arteries and that these HDLs also have anti-diabetic properties.

This is not the first time UNSW has honored Rye, who was recognized as the UNSW School of Medical Sciences Researcher of the Year in 2016. Among her other awards are several nods for research and mentoring from the American Heart Association’s Atherosclerosis, Thrombosis and Vascular Biology council. She is also an editorial board member of two AHA journals and has held multiple leadership roles within that organization.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women’s health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.